Penetration of clindamycin and its metabolite N-demethylclindamycin into cerebrospinal fluid following intravenous infusion of clindamycin phosphate in patients with AIDS

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 11, 1998, Pages 3014-3017

  Gatti, Giorgio ^a,d   Malena, Marina ^b   Casazza, Rosetta ^a   Borin, Marie ^c   Bassetti, Matteo ^a   Cruciani, Mario ^b  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

^c PFIZER INC   (United States)

^d UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CLINDAMYCIN; DRUG METABOLITE; NORCLINDAMYCIN; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CENTRAL NERVOUS SYSTEM INFECTION; CEREBROSPINAL FLUID LEVEL; CLINICAL ARTICLE; DRUG PENETRATION; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUMBAR PUNCTURE; MALE; NONHUMAN; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; TOXOPLASMA GONDII; TOXOPLASMOSIS;

EID: 0031724990     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.11.3014     Document Type: Article

References (16)

1. Brodasky, T. F., A. D. Argoudelis, and T. E. Eble. 1968. The characterization and thin layer chromatographic quantitation of the human metabolite of 7-deoxy-7(S)-chlorolincomycin. J. Antibiot. 21:327-333.
2. Clumeck, N. 1991. Some aspects of the epidemiology ot toxoplasmosis and pneumocystosis in AIDS in Europe. Eur. J. Clin. Microbiol. Infect. Dis. 10: 177-178.
3. Dannemann, B., J. A. McCutchan, D. Israelski, D. Antoniskis, C. Leport, B. Luft, J. Nussbaum, N. Clumeck, P. Morlat, J. Chiu, J.-L. Vilde, M. Orellana, D. Feigal, A. Bartok, P. Heseltine, J. Leedom, J. Remington, and the California Collaborative Treatment Group. 1992. Treatment of toxoplasmic encephalitis in patients with AIDS. A randomized trial comparing pyrimethamine plus clindamycin to pyrimethamine plus sulfadiazine. Ann. Intern. Med. 116:33-43.
4. Follette, G. L., J. Gambertoglio, J. A. White, D. W. Knuth, and E. T. Lin. 1988. Determination of clindamycin by high-performance liquid chromatography with ultraviolet detection. J. Chromatogr. 431:379-388.
5. Gatti G., J. Flaherty, J. Bubp, J. White, M. Borin, and J. Gambertoglio. 1993. Comparative study of the bioavailabilities and pharmacokinetics of clindamycin in healthy volunteers and patients with AIDS. Antimicrob. Agents Chemother. 37:1137-1143.
6. Hand, W. L., and N. L. King-Thompson. 1982. Membrane transport of clindamycin in alveolar macrophages. Antimicrob. Agents Chemother. 21: 241-247.
7. Harris, C., M. P. Salgo, H. B. Tanowitz, and M. Wittner. 1988 In vitro assessment of antimicrobial agents against Toxoplasma gondii. J. Infect. Dis. 157:14-22.
8. Hofflin, J. M., and J. S. Remington. 1987. Clindamycin in a murine model of toxoplasmic encephalitis. Antimicrob. Agents Chemother. 31:492-496.
9. Jones, J. L., D. L. Hanson, S. Y. Chu, C. A. Ciesielski, J. E. Kaplan, J. W. Ward, T. R. Navin, and the Adult/Adolescent Spectrum of Disease Group. 1996. Toxoplasmic encephalitis in HIV-infected persons: risk factors and trends. AIDS 10:1393-1399.
10. Katlama, C., S. De Wit, E. O'Doherty, M. Van Glabeke, N. Clumeck, and the European Network for Treatment of AIDS (ENTA) Toxoplasmosis Study Group. 1996. Pyrimethamine-clindamycin vs. pyrimethamine-sulfadiazine as acute and long-term therapy for toxoplasmic encephalitis in patients with AIDS. Clin. Infect. Dis. 22:268-275.
11. Lake-Bakaar, G., T. Wiston, D. Lake-Bakaar, N. Gupta, S. Beidas, M. Elsakr, and E. Straus. 1988. Gastropathy and ketoconazole malabsorption in the acquired immunodeficiency syndrome. Ann. Intern. Med. 109:471-473.
12. Luft, B. J., and J. S. Remington. 1988. Toxoplasmic encephalitis. J. Infect. Dis. 157:1-6.
13. Peloquin, C. A., A. A. McPhee, and S. E. Berning. 1993. Malabsorption of antimycobacterial medications. N. Engl. J. Med. 329:1122-1123.
14. Pfefferkorn, E. R., R. F. Nothnagel, and S. E. Borotz. 1992. Parasiticidal effect of clindamycin on Toxoplasma gondii grown in cultured cells and selection of a drug-resistant mutant. Antimicrob. Agents Chemother. 36:1091-1096.
15. Sande, M. A., and G. L. Mandell. 1996. Antimicrobial agents. In A. Goodman, A. G. Gilman, T. W. Rall, A. S. Nies, and P. Taylor (ed.), Goodman and Gilman's the pharmacological basis of therapeutics, 9th ed. Pergamon Press, New York, N.Y.
16. Wagner, J. G., E. Novak, N. C. Patel, C. G. Chidester, and W. L. Lummis. 1968. Absorption, excretion and half-life of clinimycin in normal adult males. Am. J. Med. Sci. 256:25-37.